Navigation Links
Oncology Global Strategic Marketing Study Offers Chance for Resource Benchmarks
Date:4/19/2011

CHAPEL HILL, N.C., April 19, 2011 /PRNewswire/ -- The oncology market continues to be a rapid growth area for the biopharmaceutical industry, but managing all the aspects of successfully launching a new oncology product is challenging. In particular, global strategic marketing functions supporting the oncology therapeutic area are constantly assessing the appropriate budgets and resources needed to run a high-performing group.

Best Practices, LLC, a leader in biopharmaceutical benchmark and best practice research, has launched a comprehensive study to answer questions such as:

  • Annual cost for Oncology Global Strategic Marketing operations
  • Total number of FTEs
  • Percentage of FTEs and budget allocated to six key activities
  • Current investment level trends
  • Key activities at each stage of product development

Pharma Leaders who oversee or work in Global Strategic Marketing for Oncology are invited to participate in the online survey and receive the full results at no cost. The study looks at Oncology Global Strategic Marketing activities in the United States, Europe, Asia or other headquarters locations and major markets.

This study will generate comparative metrics and executive insights that participants can use to evaluate and improve the effectiveness of their individual programs. All responses are blinded and aggregated to protect confidentiality. To participate, follow this link to the study: http://surveys.best-in-class.com/i/111848e9740690p153568

For assistance or questions related to this study, contact research team leader Martha Haswell at mhaswell@best-in-class.com or (919) 767-9249. Responses are requested by April 25, 2011.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 48 out of the top 50 pharmaceutical companies. For more information visit: http://www3.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... -- Sanovas, Inc., a life science asset holding ... its wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed ... - http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed ...
(Date:12/5/2016)... and Gateway Health proudly announce a dynamic collaboration that will ... members with specific high risk needs. In an ... of consumers, Wellbridge combines technology and population expertise with a ... daily behaviors and lifestyle. ... , , "Dealing ...
(Date:12/5/2016)... FRANCISCO , Dec. 5, 2016  Recently ... a methylation age predictor, known as Horvath,s Clock. ... offering a sample analysis service to academic and ... of any human sample, other than sperm. The ... to accurately estimate biological age versus chronological age ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... “Tatiana Sibirskaya: A Life ... story of sacrifice and enlightenment. , “Tatiana Sibirskaya: A Life Devoted ... looking for creative outlets, Carolyn gravitated toward writing through the inspiration of her ...
(Date:12/6/2016)... Aliso Viejo, California (PRWEB) , ... December 06, 2016 , ... ... which allows users to flicker, flash, and flare from clip to clip with high ... , TransFlare 4K Jewel contains 44 lens flares filmed on the RED ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Plastic Surgery, is excited to announce the arrival of the newest Sciton laser ... with the ability to use tunable non-ablative and ablative wavelengths for exceptional results. ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... relationship-marketing firm, announced today that nominations will be accepted from December 5, ... Central Awards. , Awards include the Information Security Executive® of the Year, ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive ... of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , NitroGenesis ... shown to produce NO twice as effectively and sustains NO blood levels twice ...
Breaking Medicine News(10 mins):